[Federal Register: February 21, 2008 (Volume 73, Number 35)]
[Notices]               
[Page 9591]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21fe08-92]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated November 20, 2007 and published in the Federal 
Register on November 30, 2007 (72 FR 67759), Lipomed Inc., One 
Broadway, Cambridge, Massachusetts 02142, made application to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances listed in schedule I:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
Gamma Hydroxybutyric Acid (2010)...........  I
2,5-Dimethoxy-4-[n]-                         I
 propylthiophenethylamine (7348).
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
clinical trials, research, analytical purposes, and distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Lipomed Inc. to import the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Lipomed Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with State and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-3183 Filed 2-20-08; 8:45 am]

BILLING CODE 4410-09-P